Chad Wilhelmy Named Quality Control and Regulatory Affairs VP at NeuroOne

NeuroOne Medical Technologies Corporation has welcomed a new member to its executive management team.

The company has hired Chad Wilhelmy, as vice president of Quality Control and Regulatory Affairs. Wilhelmy joins NeuroOne from HLT Medical, a subsidiary of the Bracco Group, where he was the vice president Quality Assurance.
 
“Chad’s appointment further strengthens our executive leadership team and deepens our capabilities as we build the platform for future growth and expansion”, said Dave Rosa, CEO of NeuroOne Medical Technologies Corporation. “We believe his vast experience in the medical device space will help us build the essential regulatory and quality foundation needed to realize our company’s ambitious goals.”
 
Wilhelmy has 20 years of medical device experience developing, implementing, and leading quality management systems. Prior to joining NeuroOne, he held top leadership roles at HLT Medical and at Sunshine Heart as the senior director of Quality. He has driven quality strategies from early-stage development to commercial distribution with both the U.S. Food and Drug Administration and Notified Body.

Wilhelmy earned a bachelor of science degree from the University of Wisconsin – Stout in engineering technology with an emphasis in Quality.
 
“I’m excited to join such a talented and innovative team. The applications and market opportunities for NeuroOne’s electrode technology are tremendous,” Wilhelmy said. 
 
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs.